Source link : https://www.newshealth.biz/health-news/agitation-relapse-delayed-with-dextromethorphan-bupropion/
DENVER — Dextromethorphan-bupropion (known as AXS-05) delayed time to relapse in patients with Alzheimer’s-related agitation, according to a phase III trial presented here. Compared with placebo, AXS-05 increased the time to relapse for agitation symptoms (HR 0.275, 95 % CI 0.091-0.836, P=0.014), with a 3.6-fold lower risk of relapse in patients with probable Alzheimer’s and […]
Author : News Health
Publish date : 2024-04-17 17:48:06
Copyright for syndicated content belongs to the linked Source.